ReviewClinics (Sao Paulo, Brazil)2026
Exploration of the mechanism of chemobrain related to neuroinflammation from 1994 to 2023.
Review in Clinics (Sao Paulo, Brazil), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Chemobrain as a Neuroimmune Syndrome: Mechanisms, Modifiers, and Emerging Multi-Target Therapeutic Strategies.Molecules (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background"Chemobrain", or chemotherapy-related cognitive impairment, is a well-documented clinical phenomenon. While neuroinflammation has been proposed as a key underlying mechanism, a comprehensive mapping of the knowledge structure and evolution of this specific research domain is lacking.
methodsThe authors conducted a bibliometric analysis to quantitatively and visually characterize the scholarly literature on neuroinflammation and chemobrain. A total of 923 relevant publications from the Web of Science Core Collection (1994‒2023) were analyzed using VOSviewer.
resultsThe analysis reveals a rapidly growing field, with a significant increase in publications and thematic focus on terms like cytokines, microglia, and oxidative stress in recent years. This shift signifies a move from purely descriptive studies toward mechanistic inquiry. While the United States has historically been the dominant contributor, China has emerged as a leading force in the past decade, indicating a global expansion of research interest.
conclusionThis study provides the first holistic overview of the neuroinflammation and chemobrain research landscape, delineating its thematic evolution and collaborative networks. The findings underscore that neuroinflammation remains a highly active, yet not fully elucidated, mechanistic hypothesis driving the field. A key limitation is the bibliometric nature of the study, which reflects terminological and publication trends rather than direct biological validation. Future research should focus on integrating multi-omics data and conducting longitudinal clinical studies to substantiate these mechanistic links.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.